Measurement of brain regional α[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression

Archives of General Psychiatry

Volumn 61, Issue 6, 2004, Pages 556-563

  Rosa Neto, Pedro ^a   Diksic, Mirko ^a   Okazawa, Hidehiko ^a   Leyton, Marco ^a   Ghadirian, Nayyer ^a   Mzengeza, Shadreck ^a   Nakai, Akio ^a   Debonnel, Guy ^a   Blier, Pierre ^a   Benkelfat, Chawki ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; N METHYLTRYPTOPHAN; N METHYLTRYPTOPHAN C 11; RADIOPHARMACEUTICAL AGENT; SEROTONIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BRAIN REGION; BRAIN SCINTISCANNING; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; GRAY MATTER; HOSPITAL DEPARTMENT; HUMAN; LIMBIC CORTEX; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MOOD; MORPHOMETRICS; OUTPATIENT; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PROTEIN SYNTHESIS; REGULATORY MECHANISM; TEMPORAL CORTEX; THALAMUS; TIME; UNIVERSITY HOSPITAL;

BRAIN; CARBON RADIOISOTOPES; CAUDATE NUCLEUS; CEREBRAL CORTEX; DEPRESSIVE DISORDER; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SEROTONIN; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRYPTOPHAN;

EID: 2942529391     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.61.6.556     Document Type: Article

References (74)

1. Coppen A. The biochemistry of affective disorders. Br J Psychiatry. 1967;113:1237-1264.
2. Stahl SM, Mechanism of action of serotonin selective reuptake inhibitors: serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord. 1998;51:215-235.
3. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12(suppl 1):2-19.
4. Maes M, Meltzer HY. The serotonin hypothesis of major depression. In: Bloom F, Kupfer D, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:933-944.
5. Yatham LN, Liddle PF, Shiah IS, Scarrow G, Lam RW, Adam MJ, Zis AP, Ruth TJ. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry. 2000;57:850-858.
6. Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry. 1997;171:444-448.
7. 11C]WAY-100635; effects of depression and antidepressant treatment, Arch Gen Psychiatry. 2000;57:174-180.
8. Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C. Serotonin type-1A receptor imaging in depression. Nucl Med Biol. 2000;27:499-507.
9. 123l]-2 β-carbomethoxy-3 β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry, 1998;44:1090-1098.
10. 123l]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry. 2000;47:482-489.
11. Eccleston D, Ashcroft GW, Crawford TB. 5-Hydroxyindole metabolism in the rat brain: a study of intermediate metabolism using the technique of tryptophan loading, II: applications and drug studies. J Neurochem. 1965;12:493-503.
12. Kuhar MJ, Aghajanian GK, Roth RH. Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: correlations with serotonin levels and histochemical fluorescence. Brain Res. 1972;44:165-176.
13. Burns D, London J, Brunswick DJ, Pring M, Garfinkel D, Rabinowitz JL, Mendels J. A. E. Bennett Award Paper: a kinetic analysis of 5-hydroxyindoleacetic acid excretion from rat brain and CSF. Biol Psychiatry. 1976;11:125-157.
14. Young SN, Smith SE, Pihl RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology. 1985;87:173-177.
15. Booij L, Van der Kloot WA, Benkelfat C, Bremner JD, Cowen PJ, Fava M, Gillin C, Leyton M, Moore P, Smith KA, Van der Does W. Predictors of mood response to tryptophan depletion: a reanalysis. Neuropsychopharmacology. 2002;27:852-861.
16. Shopsin B, Gershon S, Goldstein M, Friedman E, Wilk S. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun. 1975;1:239-249.
17. Smith KA, Fairburn CG, Cowen PJ. Relapse of depression after rapid depletion of tryptophan. Lancet. 1997;349:915-919.
18. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry. 1990;47:411-418.
19. 11C]-5-hydroxy-L-tryptophan for positron emission tomography assessment of serotonin synthesis in human brain. J Cereb Blood Flow Metab. 2002;22:1352-1366.
20. 11C-labelled L-tryptophan and 5-hydroxy-L-tryptophan in the rhesus monkey: a study using positron emission tomography. J Neural Transm Gen Sect. 1992;88:1-10.
21. 11C]tryptophan and its in vivo-formed radiolabeled metabolites in brain tissue using high performance liquid chromatography: a study supporting radiotracer kinetics obtained with positron emission tomography. Nucl Med Biol. 1997;24:733-738.
22. Diksic M, Young SN. Study of the brain serotonergic system with labeled α-methyl-L-tryptophan. J Neurochem. 2001;78:1185-1200.
23. Chugani DC, Muzik O. α-[C-11]Methyl-L-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab. 2000;20:2-9.
24. Cohen Z, Tsuiki K, Takada A, Beaudet A, Diksic M, Hamel E. In vivo-synthesized radioactively labelled α-methyl serotonin as a selective tracer for visualization of brain serotonin neurons. Synapse. 1995;21:21-28.
25. Gharib A, Balende C, Sarda N, Weissmann D, Plenevaux A, Luxen A, Bobillier P, Pujol JF. Biochemical and autoradiographic measurements of brain serotonin synthesis rate in the freely moving rat: a reexamination of the α-methyl-L-tryptophan method. J Neurochem. 1999;72:2593-2600.
26. 14C]methyl-L-tryptophan (α-MTrp) and its correlation with regional serotonin synthesis, tryptophan incorporation into proteins, and permeability surface area products of tryptophan and α-MTrp. Neurochem Res. 2000;25:1537-1546.
27. Baxter LR Jr, Schwartz JM, Phelps ME, Mazzlotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 1989;46:243-250.
28. Soares JC, Mann JJ. The functional neuroanatomy of mood disorders. J Psychiatr Res. 1997;31:393-432.
29. Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry. 1997;54:364-374.
30. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull. 2003;65:193-207.
31. 18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiatry. 1999;45:180-186.
32. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients [published correction appears in Am J Psychiatry. 1996;153:588]. Am J Psychiatry. 1996;153:174-182.
33. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients [published correction appears in Am J Psychiatry. 1996;153:588]. Am J Psychiatry. 1996;153:174-182.
34. First M, Spitzer R, Gibbon M, Williams JB. Structured Clinical Interview for the DSM-IV Axis I Disorders (SCID I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1995.
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:52-62.
36. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
37. 18th World Medical Asssociation General Assembly. World Medical Asssociation Declaration of Helsinki: Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects. Helsinki, Finland: World Medical Association; 1964.
38. 11C]methyl-L-tryptophan for PET studies. Nucl Med Biol. 1995;22:303-307.
39. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P, Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 1997;94:5308-5313.
40. 11C]methyl-L-tryptophan. J Psychiatry Neurosci. 2000;25:359-370.
41. 11C]methyl-tryptophan. J Cereb Blood Flow Metab. 1998;18:1121-1129.
42. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
43. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998;17:87-97.
44. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994;18:192-205.
45. Zijdenbos A, Forghani R, Evans A. Automatic quantification of MS lesions in 3D MRI brain data sets: validation of INSECT. In: Proceedings of International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI). New York, NY: Springer-Verlag NY Inc; 1998:439-448.
46. Collins DL, Zijdenbos AP, Barrẽ WFC, Evans AC. ANIMAL+INSECT: improved cortical structure segmentation. In: Kuba A, Samal M, Todd-Pokropek A, eds. Proceedings of the Annual Symposium on Information Processing in Medical Imaging. Heidelberg, Germany: Springer; 1999:210-223.
47. MacDonnald D. Program for Display and Segmentation of Surfaces and Volumes. Montreal, Quebec: McConell Brain Imaging Centre, Montreal Neurological Institute; 1996.
48. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 3rd ed. New York, NY: Harper Collins College Publishers; 1996:402-403.
49. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824-827.
50. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, Fox PT. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156:675-682.
51. Berthoz S, Artiges E, Van De Moortele PF, Poline JB, Rouquette S, Consoli SM, Martinot JL. Effect of impaired recognition and expression of emotions on frontocingulate cortices: an fMRI study of men with alexithymia. Am J Psychiatry. 2002;159:961-967.
52. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS, Dolan RJ. The anatomy of melancholia: focal abnormalities of cerebral blood flow in major depression. Psychol Med. 1992;22:607-615.
53. Bench CJ, Friston KJ, Brown RG, Frackowiak RS, Dolan RJ. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med. 1993;23:579-590.
54. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol. 2001;11:240-249.
55. Crino P, Morrison JH, Hof PR. Monoaminergic innervation of cingulate cortex. In: Vogt BA, Gabriel M, eds. Neurobiology of Cingulate Cortex and Limbic Thalamus: A Comprehensive Handbook. Boston, Mass: Birkhauser; 1993:285-310.
56. Ebert D, Ebmeier KP. The role of the cingulate gyrus in depression: from functional anatomy to neurochemistry. Biol Psychiatry. 1996;39:1044-1050.
57. Smith KA, Morris JS, Friston KJ, Cowen PJ, Dolan RJ. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry. 1999;174:525-529.
58. 15O]H2O PET response to intravenous d-fenfluramine. Am J Psychiatry. 1998;155:1241-1246.
59. Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA. Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. J Cereb Blood Flow Metab. 1996;16:418-426.
60. Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med. 1995;25:247-261.
61. Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci. 2002;5:267-271.
62. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98:6917-6922.
63. 11C] methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry. 2001;158:775-782.
64. Benkelfat C, Leyton M, Rosa Neto P, Weston F, Diksic M. Brain 5HT synthesis capacity in suicidal attempters. In: Annual Meeting of the American College of Neuropsychopharmacology (ACNP); Waikoloa, Hawaii; December 9-13, 2001. London, England: Elsevier; 2001.
65. Rusch BD, Abercrombie HC, Oakes TR, Schaefer SM, Davidson RJ. Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms. Biol Psychiatry. 2001;50:960-964.
66. Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN, Rapoport JL, Evans AC. Structural maturation of neural pathways in children and adolescents: in vivo study. Science. 1999;283:1908-1911.
67. Van Hoersen G, Morecraaft R, Vogt B. Connections of the monkey cingulate cortex. In: Vogt BA, Gabriel M, eds. Neurobiology of Cingulate Cortex and Limbic Thalamus: A Comprehensive Handbook. Boston, Mass: Birkhauser; 1993:285-310.
68. 14C] labeled tracer. J Cereb Blood Flow Metab. 2000;20:244-252.
69. Muzik O, Chugani DC, Chakraborty P, Mangner T, Chugani HT. Analysis of [C-11]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab. 1997;17:659-669.
70. Chugani DC, Chugani HT. PET: mapping of serotonin synthesis. Adv Neurol. 2000;83:165-171.
71. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry. 2000;48:813-829.
72. Woods RP. Modeling for intergroup comparisons of imaging data. Neuroimage. 1996;4:S84-S94.
73. Gogtay N, Giedd J, Rapoport JL. Brain development in healthy, hyperactive, and psychotic children. Arch Neurol. 2002;59:1244-1248.
74. Fenstermacher JD, Blasberg RG, Patlak CS. Methods for quantifying the transport of drugs across brain barrier systems. Pharmacol Ther. 1981;14:217-248.